Media Center

Tabuk pharmaceuticals enters into a partnership with pfizer in the kingdom of saudi arabia

Tabuk enters into tripartite agreement with boehringer ingelheim and cigalah

December 17, 2024

Tabuk Pharmaceuticals Partners with Bio-Thera Solutions forRights to Manufacture and Commercialize BAT2206,a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

October 9, 2024

Tabuk Pharmaceuticals Announces Exclusive Licensing Partnership with Hanmi to Introduce Innovative Value-Added Medicines in the Kingdom of Saudi Arabia and MENA Region

September 26, 2024

Biocon Limited partners with Tabuk Pharmaceuticals to commercialise its Glucagon-like peptide-1 (GLP -1) products in the Middle East region.

TABUK AND HK INNO.N PARTNER TO BRING K-CAB® (TEGOPRAZAN) AN INNOVATIVE MEDICINE TO THE MENA REGION.

Formosa Pharmaceuticals Announces Exclusive Licensing Agreement with Tabuk Pharmaceuticals, for the Commercialization of Clobetasol Propionate Ophthalmic Suspension, a Novel Medicine for the Treatment of Inflammation and Pain Following Ocular Surgery

February 2, 2024

Tabuk Pharmaceuticals and Globalpharma Sign an Agreement to Locally manufacture Key Pharmaceutical products in UAE.

Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus et justo malesuada

+966 11 4774946

+966 11 4774946

Astra Industrial Group Building No:2 – First Floor King Abdulaziz Street, Riyadh

info@tabukpharmaceuticals.com

info@tabukpharmaceuticals.com